Ablacon
Wheat Ridge, US · Founded 2015 · Delaware corporation
Founders & leadership
PR
Peter RuppersbergNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$51.5M disclosed across 2 rounds · 2019–2020
▶$30MraisedDec 2020 · 3 investors · Other TechnologyRule 506(b)
▶$30MraisedDec 2020 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Peter RuppersbergDirector
- Peter RuppersbergExecutive Officer, Director
- Peter RuppersbergExecutive Officer, Director
- Peter RuppersbergExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $30M
- Minimum investment
- $375K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$21.5MraisedMay 2019 · 2 investors · BiotechnologyRule 506(b)
▶$21.5MraisedMay 2019 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter RuppersbergExecutive Officer, Director
- Offering amount
- $21.5M
- Amount sold
- $21.5M
- Minimum investment
- $1.5M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Ablacon raised?
- Ablacon has disclosed $51.5M raised across 2 rounds.
- Where is Ablacon headquartered?
- Ablacon is headquartered in Wheat Ridge, US.